Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Abbott Laboratories (ABT), Stryker Corporation (SYK): Will Obamacare Cost You Your Job?

Is your job in jeopardy because of Obamacare? Staunch advocates of the Patient Protection and Affordable Care Act would say absolutely not. Diehard opponents would maintain that many jobs are at risk because of Obamacare. What’s the correct answer? It’s a definite “maybe.” Your job could be in jeopardy if your employer fits into of these three categories.

Abbott Laboratories (ABT)

1. Medical device companies
Several medical device companies have already slashed jobs or are planning to do so because of Obamacare. Abbott Laboratories (NYSE:ABT) began shedding the first of 1,900 jobs a few years ago. The company attributed the cuts partially to new fees and pricing pressures resulting from the Affordable Care Act.

Stryker Corporation (NYSE:SYK) executives placed blame squarely on the 2.3% medical device tax included in Obamacare as the reason for eliminating 5% of its workforce — 1,170 jobs. Most of Stryker Corporation (NYSE:SYK)’s cuts were implemented by the end of 2012 before the new taxes went into effect.

However, other medical device makers still have possible staff reductions looming on the horizon. Medtronic, Inc. (NYSE:MDT) sent 500 employees home last summer and plans to cut another 500 jobs by the end of this year. Privately held Welch Allyn expects to eliminate 10% of its jobs over the next three years.

If you work in the medical device sector, there is some hope, though, that further jobs won’t be lost. Momentum appears to be building on both sides of the aisle in Washington to either repeal or modify this particular component of Obamacare.

2. Small businesses
Obamacare requires that employers with more than 50 full-time workers provide health care coverage for employees beginning in 2014. For some small businesses, the extra costs for this coverage are forcing tough decisions. One alternative is to pay a $2,000-per-employee penalty for each worker over a 30-employee level. Some businesses will choose to pay the penalties because it’s cheaper than providing insurance.

However, other small employers could cut jobs altogether to move below the 50-employee threshold established by Obamacare. For example, a small business with 54 full-time workers could decide that eliminating five jobs makes more economic sense than paying significantly more for health coverage or penalties. Another alternative that businesses could take is to keep employees but reduce their hours to less than 30 per week so that the workers won’t be counted as full-time.

How significant are these risks of job losses from small businesses? Experts disagree, but the small businesses that appear to be most likely to face hard choices — those with 20 to 99 employees — account for more than 19 million jobs. A recent study from life insurance research organization LIMRA found that less than half of small business with fewer than 100 employees offer benefits to their employees currently.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.